Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group

OBJECTIVE: According to recent European Society of Medical Oncology, European Society of Gynaecological Oncology and European Society of Radiotherapy and Oncology guidelines, adjuvant vaginal brachytherapy (VB) is optional in patients with intermediate risk (IR) and high-intermediate risk (HIR) endo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Gynecol Oncol
Hlavní autoři: Reboux, Pierre-Alain, Azaïs, Henri, Canova, Charles-Henry, Bendifallah, Sofiane, Ouldamer, Lobna, Raimond, Emilie, Hudry, Delphine, Coutant, Charles, Graesslin, Olivier, Touboul, Cyril, Collinet, Pierre, Bricou, Alexandre, Huchon, Cyrille, Daraï, Emile, Ballester, Marcos, Lévêque, Jean, Lavoué, Vincent, Koskas, Martin, Uzan, Catherine, Canlorbe, Geoffroy
Médium: Artigo
Jazyk:Inglês
Vydáno: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6543117/
https://ncbi.nlm.nih.gov/pubmed/31074238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2019.30.e53
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky